Pfizer warns of hit to financial results on continued coronavirus outbreak

The outbreak that began in Wuhan at the end of last year has killed over 2,700 in China, with over 78,000 confirmed cases of infection, and has now spread to several other countries.

Pfizer Inc on Thursday warned that the continued spread of the coronavirus globally could have an adverse impact on its business and financial results. The outbreak could have an impact on the company's manufacturing, supply chain and clinical trial operations, Pfizer said under the risk factors section of a regulatory filing.
 

"The extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence," the drugmaker added.

The outbreak that began in Wuhan at the end of last year has killed over 2,700 in China, with over 78,000 confirmed